These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11314681)

  • 1. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
    van Laar M; Volkerts E; Verbaten M
    Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
    Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
    Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers.
    Iudice A; Bonanni E; Maestri M; Nucciarone B; Brotini S; Manca L; Iudice G; Murri L
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):304-9. PubMed ID: 12139207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.
    Idzikowski C; Mills FJ; Glennard R
    Brain Res; 1986 Jul; 378(1):164-8. PubMed ID: 3091188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritanserin-induced changes in sleep-waking phases in rats.
    Kirov R; Moyanova S
    Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
    Viola AU; Brandenberger G; Toussaint M; Bouhours P; Paul Macher J; Luthringer R
    Clin Neurophysiol; 2002 Mar; 113(3):429-34. PubMed ID: 11897543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L; Ursin R
    Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power.
    Brandenberger G; Luthringer R; Muller G; Gronfier C; Schaltenbrand N; Macher JP; Muzet A; Follenius M
    J Endocrinol Invest; 1996 Sep; 19(8):556-62. PubMed ID: 8905480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit.
    Welsh SE; Romano AG; Harvey JA
    Psychopharmacology (Berl); 1998 May; 137(2):157-63. PubMed ID: 9630002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
    Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
    Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related effect of ritanserin on the sleep-waking phases in rats.
    Kirov R; Moyanova S
    Int J Neurosci; 1998 Apr; 93(3-4):265-78. PubMed ID: 9639244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daytime sleepiness, performance, mood, nocturnal sleep: the effect of benzodiazepine and caffeine on their relationship.
    Johnson LC; Spinweber CL; Gomez SA; Matteson LT
    Sleep; 1990 Apr; 13(2):121-35. PubMed ID: 2184488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers.
    Wilson SJ; Bailey JE; Alford C; Nutt DJ
    J Psychopharmacol; 2000; 14(4):378-86. PubMed ID: 11198056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2 receptor antagonism and slow-wave sleep in major depression.
    Staner L; Kempenaers C; Simonnet MP; Fransolet L; Mendlewicz J
    Acta Psychiatr Scand; 1992 Aug; 86(2):133-7. PubMed ID: 1529736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
    Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
    Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implications of 5-HT2 receptors in the increase of slow wave sleep in healthy volunteers under amoxapine].
    Loas G
    Encephale; 1991 Dec; 17 Spec No 3():423-5. PubMed ID: 1807968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.
    da Roza Davis JM; Sharpley AL; Cowen PJ
    Psychopharmacology (Berl); 1992; 108(3):387-9. PubMed ID: 1523288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.